Assay Detail
Functional
CHEMBL4841195
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human NCI-H1650 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based assay
7
Total Activities
7
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | NCI-H1650 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[<i>g</i>]pyrrolo[2,1-<i>a</i>]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 7 | 5.46 | 6.41 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL4879183 | — | — | 1 | 6.41 |
| CHEMBL4872568 | — | — | 1 | 5.92 |
| CHEMBL4854342 | — | — | 1 | 5.85 |
| CHEMBL4874361 | — | — | 1 | 5.80 |
| CHEMBL4869983 | — | — | 1 | 5.11 |
| CHEMBL1336 | SORAFENIB | 4.0 | 1 | 4.74 |
| CHEMBL481 | IRINOTECAN | 4.0 | 1 | 4.40 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL4879183 | — | IC50 | = | 390.0 | nM | 6.41 |
| CHEMBL4872568 | — | IC50 | = | 1200.0 | nM | 5.92 |
| CHEMBL4854342 | — | IC50 | = | 1420.0 | nM | 5.85 |
| CHEMBL4874361 | — | IC50 | = | 1570.0 | nM | 5.80 |
| CHEMBL4869983 | — | IC50 | = | 7700.0 | nM | 5.11 |
| CHEMBL1336 | SORAFENIB | IC50 | = | 18090.0 | nM | 4.74 |
| CHEMBL481 | IRINOTECAN | IC50 | = | 39670.0 | nM | 4.40 |